4-HO-DET: Difference between revisions
>Tracer m Added Category:Hallucinogen |
>M4nu5l m Citation added |
||
(45 intermediate revisions by 7 users not shown) | |||
Line 4: | Line 4: | ||
'''4-Hydroxy-N,N-diethyltryptamine''' (also known as '''4-HO-DET''', '''CZ-74''', and '''Ethocin''') is a lesser-known synthetic [[psychoactive class::psychedelic]] of the [[chemical class::tryptamine]] chemical class that produces [[psilocin]]-like [[psychedelic]] effects when [[Routes of administration|adminstered]]. 4-HO-DET is a close structural and functional analog of [[psilocin]] (4-HO-DMT), the principal psychoactive component in [[magic mushrooms]]. It is notable for sharing many of its core features while retaining subtle variations in its duration, visual, cognitive and bodily effects. | '''4-Hydroxy-N,N-diethyltryptamine''' (also known as '''4-HO-DET''', '''CZ-74''', and '''Ethocin''') is a lesser-known synthetic [[psychoactive class::psychedelic]] of the [[chemical class::tryptamine]] chemical class that produces [[psilocin]]-like [[psychedelic]] effects when [[Routes of administration|adminstered]]. 4-HO-DET is a close structural and functional analog of [[psilocin]] (4-HO-DMT), the principal psychoactive component in [[magic mushrooms]]. It is notable for sharing many of its core features while retaining subtle variations in its duration, visual, cognitive and bodily effects. | ||
This compound was first discovered in the late 1950s by [[Albert Hofmann]] and Franz Troxler<ref>Therapeutic indoles for psychic stimulation and relief of mental depression | | This compound was first discovered in the late 1950s by [[wikipedia:Albert Hofmann|Albert Hofmann]] and Franz Troxler<ref>{{cite web|title=US Patent 3072530 - Therapeutic indoles for psychic stimulation and relief of mental depression|url=https://patents.google.com/patent/US3072530/en|access-date=July 18, 2020|website=Google Patents}}</ref><ref>{{cite web|url=https://www.erowid.org/archive/rhodium/pdf/psilocin.esters.pdf|publisher=United States Patent Office|title=Esters of Indoles|date=January 29, 1963|id=3,075,992}}</ref> in their investigation of various [[psychedelic]] compounds that were structurally and chemically related to the principle active components he isolated from [[magic mushrooms]], [[psilocybin]] ('''4-PO-DMT''') and [[psilocin]] ('''4-HO-DMT'''). The substance was used together with its phosphoryloxy-analog [[wikipedia:4-PO-DET|4-PO-DET]] in human clinical trials in the 1960s by the German researchers Hanscarl Leuner <ref>"Psycholytische Therapie nach Hanscarl Leuner – Grundlagen, Praxis, Perspektiven" (in German), Torsten Passie, Michael Schlichting, Ralf Bolle (published September, 2023).</ref> and G. Baer. | ||
Since its inception, 4-HO-DET has remained relatively uncommon and has very little documentation of human usage, with the majority of [[psychedelic]] users preferring more traditional [[psychedelics]] like the [[psilocybin]] and [[psilocin]] in [[psilocybin mushrooms]], or more recently, [[4-AcO-DMT]]. Today, it is either used as a recreational substance or an [[entheogen]], has no documentation of being sold on the streets and is primarily acquired through the use of online [[research chemical]] vendors. | Since its inception, 4-HO-DET has remained relatively uncommon and has very little documentation of human usage, with the majority of [[psychedelic]] users preferring more traditional [[psychedelics]] like the [[psilocybin]] and [[psilocin]] in [[psilocybin mushrooms]], or more recently, [[4-AcO-DMT]]. Today, it is either used as a recreational substance or an [[entheogen]], has no documentation of being sold on the streets and is primarily acquired through the use of online [[research chemical]] vendors. | ||
Line 64: | Line 64: | ||
*'''[[Effect::Transformations]]''' | *'''[[Effect::Transformations]]''' | ||
*'''[[Effect::Internal hallucination]]''' (''[[effect::autonomous entities]]''; ''[[effect::settings, sceneries, and landscapes]]''; ''[[effect::perspective hallucinations]]'' and ''[[effect::scenarios and plots]]'') | *'''[[Effect::Internal hallucination]]''' (''[[effect::autonomous entities]]''; ''[[effect::settings, sceneries, and landscapes]]''; ''[[effect::perspective hallucinations]]'' and ''[[effect::scenarios and plots]]'') | ||
*'''[[Effect::External hallucination]]''' (''[[effect::autonomous entities]]''; ''[[effect::settings, sceneries, and landscapes]]''; ''[[effect::perspective hallucinations]]'' and ''[[effect::scenarios and plots]]'') | |||
}} | }} | ||
Line 101: | Line 102: | ||
{{#ask: [[Category:4-HO-DET]][[Category:Experience]]|format=ul|Columns=1}} | {{#ask: [[Category:4-HO-DET]][[Category:Experience]]|format=ul|Columns=1}} | ||
Additional experience reports can be found here: | Additional experience reports can be found here: | ||
* [https://www.erowid.org/experiences/subs/exp_4HODET.shtml Erowid Experience Vaults: 4-HO-DET] | |||
*[https://www.erowid.org/experiences/subs/exp_4HODET.shtml Erowid Experience Vaults: 4-HO-DET] | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
Line 112: | Line 114: | ||
4-HO-DET is [[Addiction potential::not habit-forming]] and the desire to use it can actually decrease with use. It is most often self-regulating. | 4-HO-DET is [[Addiction potential::not habit-forming]] and the desire to use it can actually decrease with use. It is most often self-regulating. | ||
Tolerance to the effects of 4-HO-DET | Tolerance to the effects of 4-HO-DET is built [[Time to full tolerance::almost immediately after ingestion]]. After that, it takes about [[Time to half tolerance::3 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::7 days]] to be back at baseline (in the absence of further consumption). 4-HO-DET presents cross-tolerance with [[Cross-tolerance::all [[psychedelic]]s]], meaning that after the consumption of 4-HO-DET all psychedelics will have a reduced effect. | ||
===Dangerous interactions=== | ===Dangerous interactions=== | ||
Line 118: | Line 120: | ||
{{DangerousInteractions/Psychedelics}} | {{DangerousInteractions/Psychedelics}} | ||
== | ==Legal status== | ||
{{legalStub}} | {{legalStub}} | ||
*'''United Kingdom''' | |||
*'''United States''' | *'''Germany''': 4-HO-DET is controlled under Anlage I BtMG<ref>{{cite web|url=https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html|title=Gesetz über den Verkehr mit Betäubungsmitteln: Anlage I|publisher=Bundesamt für Justiz [Federal Office of Justice]|access-date=December 10, 2019|language=de}}</ref> (''Narcotics Act, Schedule I''), former: Opiumgesetz (''Opium Act'') as of February 25, 1967.<ref>{{cite web|url=http://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl167s0197.pdf|title=Vierte Verordnung über die den Betäubungsmitteln gleichgestellten Stoffe|publisher=Bundesanzeiger Verlag|work=Bundesgesetzblatt Teil I: 1967 Nr. 10|publication-date=February 24, 1967|language=de|issn=0341-1095|page=197|}}</ref> It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.<ref>{{cite web|url=https://www.gesetze-im-internet.de/btmg_1981/__29.html|title=Gesetz über den Verkehr mit Betäubungsmitteln: § 29|publisher=Bundesamt für Justiz [Federal Office of Justice]|access-date=December 10, 2019|language=de}}</ref> | ||
*'''Sweden:''' 4-HO-DET is classified as a health hazard under the Act on the Prohibition of Certain Goods Dangerous to Health as of November 1, 2005 in the regulation SFS 2005:733, making it illegal to sell or possess.<ref>{{cite web|title=Svensk författningssamling Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor|url=http://www.notisum.se/rnp/sls/sfs/20050733.pdf|id=SFS 2005:733|language=sv|date=October 6, 2005|publication-date=October 18, 2005|}}</ref> | |||
*'''Switzerland''': 4-HO-DET is a controlled substance specifically named under Verzeichnis E.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref> | |||
*'''United Kingdom''': 4-HO-DET is a Class A drug in the United Kingdom as a result of the tryptamine catch-all clause.<ref>{{cite web|title=Schedule 2: Part I: Class A Drugs|url=http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I|work="Misuse of Drugs Act 1971"|access-date=August 20, 2020|publisher=UK Government}}</ref> | |||
*'''United States''': 4-HO-DET is unscheduled in the United States. It may be considered an analogue of [[psilocin]] (''4-HO-DMT'') which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act.{{citation needed}} | |||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Research chemical]] | *[[Research chemical]] | ||
Line 135: | Line 141: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/4-HO-DET 4-HO-DET (Wikipedia)] | *[https://en.wikipedia.org/wiki/4-HO-DET 4-HO-DET (Wikipedia)] | ||
*[https://isomerdesign.com/PiHKAL/read.php?domain=tk&id=16 4-HO-DET (TiHKAL / Isomer Design)] | *[https://isomerdesign.com/PiHKAL/read.php?domain=tk&id=16 4-HO-DET (TiHKAL / Isomer Design)] | ||
*[https://isomerdesign.com/PiHKAL/explore.php?id=5057 4-HO-DET phosphate ester (Isomer Design)] | *[https://isomerdesign.com/PiHKAL/explore.php?id=5057 4-HO-DET phosphate ester (Isomer Design)] | ||
Line 142: | Line 148: | ||
==References== | ==References== | ||
<references/> | <references /> | ||
[[Category:Substance]] | |||
[[Category:Psychoactive substance]] | [[Category:Psychoactive substance]] | ||
[[Category:Hallucinogen]] | [[Category:Hallucinogen]] | ||
[[Category:Psychedelic]] | [[Category:Psychedelic]] | ||
[[Category:Tryptamine]] | [[Category:Tryptamine]] | ||
[[Category:Research chemical]] | |||
{{#set:Featured=true}} | {{#set:Featured=true}} |